Trellus Health Extends Pfizer IBD Digital Application Licensing Agreement, Highlighting Resilience-Driven Platform's Value Across Pharmaceutical Lifecycle

Morgan Stanley Maintains Equal-Weight on Pfizer, Raises Price Target to $28

Morgan Stanley analyst Terence Flynn maintains Pfizer (NYSE:PFE) with a Equal-Weight and raises the price target from $27 to $28.

Study Showing 50% Drop In COVID ER Visits Thanks To The Vaccine Put On Hold By CDC: Report

The CDC has reportedly delayed a report showing COVID-19 vaccine benefits, citing methodology concerns.

4 Health Care Stocks Whale Activity In Today's Session

B of A Securities Maintains Neutral on Pfizer, Lowers Price Target to $26

B of A Securities analyst Jason Gerberry maintains Pfizer (NYSE:PFE) with a Neutral and lowers the price target from $27 to $26.

Novavax Faces Shareholder Revolt As Shah Capital Criticizes Strategy

Shah Capital plans to oppose Novavax board and pay, citing weak returns, high costs, and strategic missteps despite the vaccine pipeline.

Why Is Pfizer Stock Dropping Tuesday?

Pfizer Inc (NYSE:PFE) shares are trading lower on Tuesday after the company and its COVID-19 vaccine partner paused an updated-shot trial.

Corbus Offers Upside Despite Post-FDA Update, Analyst Highlights Competitive Edge

Corbus reports FDA alignment on the CRB-701 path, as analysts flag upside tied to the head and neck cancer opportunity and obesity pipeline.

CDC Halts Testing For 27 Infectious Diseases Including COVID-19, Rabies Amid Agency Downsizing

CDC pauses 27 infectious disease tests, including COVID-19, rabies, amid downsizing under HHS, while some tests remain commercially available.

Trump Administration Prepares 100% Tariffs On Drugmakers Without Pricing Deals: Report

According to a Bloomberg report, Trump may impose 100% tariffs on drugmakers without pricing deals, as part of a broader push to lower drug costs.